Frizzled Receptors as Potential Therapeutic Targets in Human Cancers

被引:74
|
作者
Zeng, Chui-Mian [1 ,2 ]
Chen, Zhe [3 ]
Fu, Li [1 ,2 ]
机构
[1] Shenzhen Univ, Sch Med, Dept Pharmacol, Guangdong Key Lab Genome Stabil & Dis Prevent, Shenzhen 518060, Peoples R China
[2] Shenzhen Univ, Sch Med, Carson Int Canc Res Ctr, Shenzhen 518060, Peoples R China
[3] Zhejiang Chinese Med Univ, Zhejiang Hosp Tradit Chinese Med, Zhejiang Key Lab Gastrointestinal Pathophysiol, Hangzhou 310006, Zhejiang, Peoples R China
基金
国家重点研发计划; 中国国家自然科学基金;
关键词
frizzled receptors; WNT signaling pathway; cancer therapy; antibody; small molecule inhibitor; WNT/BETA-CATENIN PATHWAY; CELL LUNG-CANCER; EPITHELIAL-MESENCHYMAL TRANSITION; NEGATIVE BREAST-CANCER; ACUTE MYELOID-LEUKEMIA; HUMAN SYNOVIAL SARCOMA; STEM-LIKE CELLS; DOWN-REGULATION; BETA-CATENIN; SIGNALING PATHWAY;
D O I
10.3390/ijms19051543
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Frizzled receptors (FZDs) are a family of seven-span transmembrane receptors with hallmarks of G protein-coupled receptors (GPCRs) that serve as receptors for secreted Wingless-type (WNT) ligands in the WNT signaling pathway. Functionally, FZDs play crucial roles in regulating cell polarity, embryonic development, cell proliferation, formation of neural synapses, and many other processes in developing and adult organisms. In this review, we will introduce the basic structural features and review the biological function and mechanism of FZDs in the progression of human cancers, followed by an analysis of clinical relevance and therapeutic potential of FZDs. We will focus on the development of antibody-based and small molecule inhibitor-based therapeutic strategies by targeting FZDs for human cancers.
引用
收藏
页数:18
相关论文
共 50 条
  • [21] Kinins and Their Receptors as Potential Therapeutic Targets in Retinal Pathologies
    Othman, Rahmeh
    Cagnone, Gael
    Joyal, Jean-Sebastien
    Vaucher, Elvire
    Couture, Rejean
    CELLS, 2021, 10 (08)
  • [22] AT2 Receptors: Potential Therapeutic Targets for Hypertension
    Carey, Robert M.
    AMERICAN JOURNAL OF HYPERTENSION, 2017, 30 (04) : 339 - 347
  • [23] RON in hepatobiliary and pancreatic cancers: Pathogenesis and potential therapeutic targets
    Chen, Shao-Long
    Wang, Guo-Ping
    Shi, Dan-Rong
    Yao, Shu-Hao
    Chen, Ke-Da
    Yao, Hang-Ping
    WORLD JOURNAL OF GASTROENTEROLOGY, 2021, 27 (20) : 2507 - 2520
  • [24] Cytokines as Potential Therapeutic Targets and their Role in the Diagnosis and Prediction of Cancers
    Uchendu, Ikenna
    Zhilenkova, Angelina
    Pirogova, Yuliya
    Basova, Maria
    Bagmet, Leonid
    Kohanovskaia, Iana
    Ngaha, Yvan
    Ikebunwa, Obinna
    Sekacheva, Marina
    CURRENT PHARMACEUTICAL DESIGN, 2023, 29 (32) : 2552 - 2567
  • [25] RON in hepatobiliary and pancreatic cancers: Pathogenesis and potential therapeutic targets
    Shao-Long Chen
    Guo-Ping Wang
    Dan-Rong Shi
    Shu-Hao Yao
    Ke-Da Chen
    Hang-Ping Yao
    World Journal of Gastroenterology, 2021, 27 (20) : 2507 - 2520
  • [26] Potential therapeutic targets in ARID1A-mutated cancers
    Bitler, Benjamin G.
    Fatkhutdinov, Nail
    Zhang, Rugang
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2015, 19 (11) : 1419 - 1422
  • [27] ITCH as a potential therapeutic target in human cancers
    Yin, Qing
    Wyatt, Clayton J.
    Han, Tao
    Smalley, Keiran S. M.
    Wan, Lixin
    SEMINARS IN CANCER BIOLOGY, 2020, 67 : 117 - 130
  • [28] N-Glycoproteomic Landscape of Human Lymphoid Cancers Reveals Novel Biomarkers and Potential Therapeutic Targets
    Rolland, Delphine C. M.
    Basrur, Venkatesha
    Jeon, Yoon Kyung
    McNeil-Schwalm, Carla
    Fermin, Damian
    Conlon, Kevin
    Tsou, Chih-Chiang
    Brown, Noah A.
    Thomas, Dafydd G.
    Bailey, Nathanael G.
    Omenn, Gilbert S.
    Nesvizhskii, Alexey I.
    Lim, Megan S.
    Elenitoba-Johnson, Kojo S. J.
    BLOOD, 2015, 126 (23)
  • [29] Novel Therapeutic Targets in Cancers
    Levantini, Elena
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (19)
  • [30] Neuropeptide Y and its receptors as potential therapeutic drug targets
    Silva, AP
    Cavadas, C
    Grouzmann, E
    CLINICA CHIMICA ACTA, 2002, 326 (1-2) : 3 - 25